The Temporal Requirements for Androgens During the Cell Cycle of the Prostate Gland
Dr. William Wallace Scott has focused a considerable portion of his efforts toward defining the clinical parameters and physiological factors which are important in understanding and controlling the growth of the prostate gland. Dr. Scott defined the ultimate clinical goal in his statement, “What a glorious day it will be for urology when we can shrink the benign nodular hyperplastic prostate, quiet the carcinomatous one and increase the libido and potentia all with a tablet. Oh happy day!”(1) Dr. Scott has initiated this long and difficult journey through a series of contributions which have formed a systematic framework for the evaluation and search for new inhibitors of prostatic growth(1–18). This has been exemplified by his leadership in the recent development of antiandrogenic drugs, which introduce a great deal of promise as a new approach for the effective treatment of benign nodular prostatic hyperplasia and prostatic carcinoma(12,14,17,18).
KeywordsProstate Gland Cyproterone Acetate Ventral Prostate Prostatic Growth Testosterone Propionate
Unable to display preview. Download preview PDF.
- 3.Scott, W. W. Regulators of prostatic growth. Trans. Am. Assoc. Genitourin. Surg. 58: 168, 1956.Google Scholar
- 6.Scott, W. W., and Schirmer, H. K. A. Hypophysectomy for disseminated prostatic cancer. In On Cancer and Hormones, University of Chicago Press, Chicago, 1962.Google Scholar
- 7.Scott, W. W. Growth and development of the human prostate. In Biology of the Prostate and Related Tissues, U.S.P.H. Monograph No. 12, p. 111, 1963.Google Scholar
- 13.Robson, M. C., and Scott, W. W. Effect of portal diversion of testicular blood on prostatic secretion in the dog. Invest. Urol. 1: 92, 1964.Google Scholar
- 2.Baserga, R. Biochemistry of Cell Division, Charles C. Thomas, Publisher, Springfield, III., pp. 3–5, 1969Google Scholar
- 3.Fang, S., and Liao, S. Antagonistic action of anti-androgens on the formation of a specific dihydrotestosterone receptor protein complex in rat ventral prostate. Molec. Pharmacol. 5: 420, 1969.Google Scholar